Hydromorphone Hydrochloride Injection shortage
Current 26 presentations · 4 manufacturers · first FDA posting Oct 31, 2017 · last update Oct 15, 2026
Manufacturers: Fresenius Kabi USA, LLC, Hikma Pharmaceuticals USA, Inc., Hospira, Inc., a Pfizer Company, Teva Pharmaceuticals USA, Inc.
Stated reasons (per FDA): Demand increase for the drug; Other
More info: FDA Drug Shortages Database · ASHP drug shortages list (search there for this drug)
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 63323-851-10) | Fresenius Kabi USA, LLC | Current Available |
— | Check wholesalers for inventory | Posted Oct 31, 2017 Updated Oct 15, 2026 |
| Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 63323-851-15) | Fresenius Kabi USA, LLC | Current Available |
— | Check wholesaler for inventory | Posted Oct 31, 2017 Updated Oct 15, 2026 |
| Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 63323-851-50) | Fresenius Kabi USA, LLC | Current Available |
— | Check wholesalers for inventory | Posted Oct 31, 2017 Updated Oct 15, 2026 |
| Hydromorphone Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-852-25) | Fresenius Kabi USA, LLC | Current Available |
— | Check wholesalers for inventory | Posted Oct 31, 2017 Updated Oct 15, 2026 |
| Hydromorphone Hydrochloride, Injection, 2 mg/1 mL (NDC 63323-853-25) | Fresenius Kabi USA, LLC | Current Available |
— | Check wholesalers for inventory | Posted Oct 31, 2017 Updated Oct 15, 2026 |
| Hydromorphone Hydrochloride, Injection, 4 mg/1 mL (NDC 63323-854-10) | Fresenius Kabi USA, LLC | Current Available |
— | Check wholesalers for inventory | Posted Nov 1, 2017 Updated Oct 15, 2026 |
| Dilaudid, Injection, 1 mg/1 mL (NDC 76045-009-06) | Fresenius Kabi USA, LLC | Current Unavailable |
Other | Next release October 2026. Check wholesalers for inventory. | Posted Oct 31, 2017 Updated Oct 15, 2026 |
| Dilaudid, Injection, 1 mg/1 mL (NDC 76045-009-11) | Fresenius Kabi USA, LLC | Current Unavailable |
Other | Next release October 2026. Check wholesalers for inventory. | Posted Oct 31, 2017 Updated Oct 15, 2026 |
| Dilaudid, Injection, 2 mg/1 mL (NDC 76045-010-11) | Fresenius Kabi USA, LLC | Current Unavailable |
Other | Next release not available at this time. Check wholesalers for inventory. | Posted Nov 1, 2017 Updated Oct 15, 2026 |
| Dilaudid, Injection, .2 mg/1 mL (NDC 76045-121-11) | Fresenius Kabi USA, LLC | Current Unavailable |
Other | Next release October 2026. Check wholesalers for inventory. | Posted Nov 1, 2017 Updated Oct 15, 2026 |
| Hydromorphone Hydrochloride, Injection, 2 mg/1 mL (NDC 0641-0121-25) | Hikma Pharmaceuticals USA, Inc. | Current Available |
— | Additional lots are scheduled for manufacturing to meet demand. Product will be made available as it is released. | Posted Nov 3, 2017 Updated Oct 14, 2026 |
| Hydromorphone Hydrochloride, Injection, 2 mg/1 mL (NDC 0641-6254-01) | Hikma Pharmaceuticals USA, Inc. | Current Unavailable |
Demand increase for the drug | Product temporarily on backorder. Additional lots will be available in the November 2026 timeframe. | Posted Nov 1, 2017 Updated Oct 14, 2026 |
| Hydromorphone Hydrochloride, Injection, 1 mg/1 mL Syringes (NDC 0409-1283-31) | Hospira, Inc., a Pfizer Company | Current Available |
— | Posted Oct 31, 2017 Updated Oct 8, 2026 | |
| Hydromorphone Hydrochloride, Injection, 1 mg/1 mL (NDC 0409-1283-37) | Hospira, Inc., a Pfizer Company | Current Unavailable |
Other | Next Delivery: January 2027; Estimated Recovery: March 2027; Shortage per Manufacturer: Manufacturing Delay | Posted Oct 31, 2017 Updated Oct 8, 2026 |
| Hydromorphone Hydrochloride, Injection, 4 mg/1 mL Syringes (NDC 0409-1304-31) | Hospira, Inc., a Pfizer Company | Current Available |
— | Posted Oct 31, 2017 Updated Oct 8, 2026 | |
| Hydromorphone Hydrochloride, Injection, 2 mg/1 mL Syringes (NDC 0409-1312-30) | Hospira, Inc., a Pfizer Company | Current Available |
— | Posted Oct 31, 2017 Updated Oct 8, 2026 | |
| Hydromorphone Hydrochloride, Injection, 2 mg/1 mL (NDC 0409-1312-36) | Hospira, Inc., a Pfizer Company | Current Limited Availability |
Other | Limited Supply Available. Next Delivery: January 2027; Estimated Recovery: March 2027; Shortage per Manufacturer: Manufacturing Delay | Posted Oct 31, 2017 Updated Oct 8, 2026 |
| Hydromorphone Hydrochloride, Injection, 0.25 mg/ 0.5 mL NexJect™ Single-dose Syringe Luer Lock (no needle) (NDC 0409-1805-01) | Hospira, Inc., a Pfizer Company | Current Unavailable |
Other | Next Delivery: January 2027; Estimated Recovery: March 2027; Shortage per Manufacturer: Manufacturing Delay | Posted Nov 1, 2017 Updated Oct 8, 2026 |
| Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 0409-2634-01) | Hospira, Inc., a Pfizer Company | Current Available |
— | Posted Oct 31, 2017 Updated Oct 8, 2026 | |
| Hydromorphone Hydrochloride, Injection, 50 mg/5 mL (10 mg/mL) (NDC 0409-2634-05) | Hospira, Inc., a Pfizer Company | Current Available |
— | Posted Oct 31, 2017 Updated Oct 8, 2026 | |
| Hydromorphone Hydrochloride, Injection, 500 mg/50 mL (10 mg/mL) (NDC 0409-2634-50) | Hospira, Inc., a Pfizer Company | Current Available |
— | Posted Oct 31, 2017 Updated Oct 8, 2026 | |
| Hydromorphone Hydrochloride, Injection, 2 mg/1 mL (NDC 0409-3365-10) | Hospira, Inc., a Pfizer Company | Current Available |
— | Posted Oct 31, 2017 Updated Oct 8, 2026 | |
| Hydromorphone Hydrochloride, Injection, 0.5 mg/0.5 mL NexJect™ Single-dose Syringe Luer Lock (no needle) (NDC 0409-4264-01) | Hospira, Inc., a Pfizer Company | Current Limited Availability |
Other | Limited Supply Available. Next Delivery: October 2026; Estimated Recovery: March 2027; Shortage per Manufacturer: Manufacturing Delay | Posted Nov 1, 2017 Updated Oct 8, 2026 |
| Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 0703-0018-01) | Teva Pharmaceuticals USA, Inc. | Current Available |
— | Posted Nov 1, 2017 Updated Oct 15, 2026 | |
| Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 0703-0110-03) | Teva Pharmaceuticals USA, Inc. | Current Available |
— | Posted Nov 1, 2017 Updated Oct 15, 2026 | |
| Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 0703-0113-03) | Teva Pharmaceuticals USA, Inc. | Current Limited Availability |
Other | Estimated recovery: October 2026 | Posted Nov 1, 2017 Updated Oct 15, 2026 |